2020
DOI: 10.1186/s40545-020-00256-w
|View full text |Cite
|
Sign up to set email alerts
|

The Urgent Need for Transparent and Accountable Procurement of Medicine and Medical Supplies in Times of COVID-19 Pandemic

Abstract: The COVID-19 pandemic has unleashed unprecedented and complex public policy issues. One that has emerged as a challenge for many countries globally is how to ensure the efficient and effective procurement of quality medical supplies. Existing corruption pressures on procurement—everything from undue influence to the outright bribery of public officials—has been amplified by the pandemic, and thus demands commensurate policy responses. We argue that transparency and accountability in procurement are essential t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
33
0
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(35 citation statements)
references
References 3 publications
(4 reference statements)
1
33
0
1
Order By: Relevance
“…This means that research must be done into the home country of an OP and the country from which the purchases are delivered [13]. A number of risks to patient safety exist when purchasing medication online without the traditional supply network, including the risk of receiving falsified medication [16][17][18].…”
Section: Introductionmentioning
confidence: 99%
“…This means that research must be done into the home country of an OP and the country from which the purchases are delivered [13]. A number of risks to patient safety exist when purchasing medication online without the traditional supply network, including the risk of receiving falsified medication [16][17][18].…”
Section: Introductionmentioning
confidence: 99%
“…If COVID-19 vaccines are to be allocated privately, it will be essential to develop policies to ensure that private allocation does not jeopardize a country’s ability to acquire the doses necessary for government-managed vaccination campaigns. Ideally, any private access would complement public provision to maximize the health and economic gains of vaccination and minimize the potential for corruption ( 38 ).…”
Section: Discussionmentioning
confidence: 99%
“…If COVID-19 vaccines are to be allocated privately, it will be essential to develop policies to ensure that private allocation does not jeopardize a country’s ability to acquire the doses necessary for government-managed vaccination campaigns. Ideally, private access would complement public provision to maximize the health and economic gains of vaccination and minimise the potential for corruption ( 34 ).…”
Section: Discussionmentioning
confidence: 99%